chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bell's Palsy right side of face; irregular menstrual cycle (two cycles within ten days); Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11Nov2021 17:15 (Lot number: FN8030) at the age of 40 years as dose 3 (booster) single for covid-19 immunisation. Relevant medical history included: "known allergies: penicillin" (unspecified if ongoing), notes: known allergies: penicillin; "Lumbar Spine epidural" (unspecified if ongoing). Concomitant medication(s) included: BOTOX. Past drug history included: Cephalosporin, reaction(s): "Known allergies: cephalosporin", notes: known allergies: penicillin, cephalosporin (rocephin),, benzyl salicylate; Benzyl salicylate, reaction(s): "Known allergies: benzyl salicylate", notes: known allergies: penicillin, cephalosporin (rocephin),, benzyl salicylate. Vaccination history included: Bnt162b2 (manufacturer: Pfizer (lot number: ER8732) dose 2 on 26Mar2021 02:00 PM, right arm), administration date: 26Mar2021, when the patient was 39 years old, for COVID-19 immunization; Bnt162b2 (manufacturer: Pfizer (lot number: EN6206) dose 1 on 05Mar2021 01:30 PM, right arm), administration date: 05Mar2021, when the patient was 39 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (medically significant) with onset 11Nov2021 17:15, outcome "not recovered", described as "Booster"; BELL'S PALSY (medically significant) with onset 16Nov2021 15:00, outcome "not recovered", described as "Bell's Palsy right side of face"; MENSTRUATION IRREGULAR (non-serious) with onset 16Nov2021 15:00, outcome "not recovered", described as "irregular menstrual cycle (two cycles within ten days)". The events "booster", "bell's palsy right side of face" and "irregular menstrual cycle (two cycles within ten days)" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (18Dec2021) negative, notes: Nasal Swab; (21Dec2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of bell's palsy, menstruation irregular. Clinical course: the patient had bell's palsy right side of face, irregular menstrual cycle (two cycles within ten days). The patient did not receive any other vaccine in four weeks. The patient had no covid prior vaccination and had not been tested for covid-19 post vaccination.   Follow-up attempts are completed. No further information is expected.
I received my first two doses of the Moderna covid vaccine in Jan/Feb 2021. On September 24, 2021 I was treated with a hyaluronic acid based dermal filler in my under eye area. The about 22 hours after my Moderna booster vaccine administration,  I noted swelling  of the undereye filler and tenderness to palpate. I contacted my provider and he prescribed a Medrol dose pack, which I took the first dose of on 1/9/22 after no improvement in symptoms.  As of 10:36pm on 1/9/22 there is slight improvement, but still noticeable swelling and tenderness to palpate area of dermal filler injection.
Client was vaccinated with Pfizer vaccine for Covid on April 10 and May 1, 2021.  She developed Covid symptoms on July 1, 2021 (nasal congestion, chest congestion, fatigue, mild myalgia, sore throat, mild loss of taste and smell).  She tested positive with rapid test on July 4, 2021.  This case being reported as client was fully vaccinated against Covid illness and became symptomatic and tested positive over 2 weeks s/p vaccination.
Patient's arm developed some swelling and redness. It peaked a day or so after vaccination and has slowly improved. She received a FLUZONE HIGH DOSE shot in the same arm as well. The shots were administered more than 1 inch apart.
Did not have an adverse reaction so much to the vaccine as to the way it was administered.  A nerve was hit in my arm.  It has been miserable.  Much loss of sleep.
Chest pains, swollen lymph nodes under arms, and large bruising within a few days.
03/02/2015 Pain at injection site, tenderness, slight swelling and redness developed over the course of the first day. Injection site stiffening and warm to the touch. 03/03/2015 Previous days' symptoms persist and continue to escalate. Swelling goes from the size of a quarter in the morning to a half dollar by the evening of day 2, 03/03/2015.  New symptoms include pain in the left pollicis muscles, problems grasping with left hand/ diminishing fine motor skills in left hand, pain in left mandibular joint, extreme fatigue to the point of canceling work, nausea, headache, fever at 101.4 degrees Fahrenheit by the afternoon, chills, sore throat and cough with phlegm. 03/04/2015 Similar to day 2, 03/03/2015. Fine motor skills in left hand have returned, but pain is still slight in pollicis muscles of left hand, fever has been maintained at 100 degrees Fahrenheit and under.  Swelling, pain, redness and stiffening at injection site are now the size of a softball in circumference and hot to the touch. Still had to cancel work from exhaustion.  Cough with phlegm worse. Nausea and stomach pain present. 03/05/2015 No hand issues or fever. Swelling has partially decreased to the size of a baseball. Injection site's redness has deepened to a reddish-brown. Injection site itches and hot to touch.  Uncontrollable coughing and sneezing. Suspected cellulitis at injection site by OB-GYN Dr. and asked to come in the next day for a quick observation. 03/06/2015 "Redness" fading but same size.  Still tender, skin is stiff and itchy at injection site between the size of a 1/2 dollar and baseball. Uncontrollable coughing and sneezing. Diagnosed with cellulitis at injection site by Dr. at 5:15 PM. Prescribed antibiotic. 03/07/2015 Day of VAERS report. Injection site problems persist, as well as uncontrollable coughing and sneezing, now suffering with laryngitis.
Pt began c/o "not feeling right" with her tongue "feeling funny" and her lips tingling approximately 5 minutes after the administration of the Moderna COVID19 vaccine.  Pt was transported to the Emergency Department for care and monitoring and was discharged when symptoms had resolved after approximately one hour.
gen hives w/wheals & flares approx 2hrs p/vax;s/s disappeared w/in 3hrs upon administrations of DPH p/o
Received Expired dose of vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired dose of vaccine) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired dose of vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired dose of vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. Concomitant medications were not reported by the reporter. Treatment details was not reported by the reporter.
complaints of insomnia; anxiety; heart palpitations; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old male patient received bnt162b2 (BNT162B2), administration date 20Apr2021 (Lot number: EW0161) at the age of 45 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (first dose, LOT: EP7534), administration date: 30Mar2021, when the patient was 45 years old, for Covid-19 immunization. The following information was reported: INSOMNIA (non-serious) with onset 2021, outcome "unknown", described as "complaints of insomnia"; ANXIETY (non-serious) with onset 2021, outcome "unknown", described as "anxiety"; PALPITATIONS (non-serious) with onset 2021, outcome "unknown", described as "heart palpitations".  Additional information:Patient after receiving the Pfizer Covid-19 vaccine started having complaints of insomnia and anxiety two weeks after receiving the second dose and stated that these complaints were causing him distress and he was not working. The reporter stated that when he first recognized it, it was about 12 or 13 days, somewhere between a week or two after second dose that he had insomnia. Further he said that he had never experienced this until after his second dose, around two weeks probably. He said that the insomnia had been the same ever since, some days he slept a couple hours, and some days he did not sleep at all or some nights he did not sleep at all. He said that he also had like heart palpitations, like anxiety.  No follow-up attempts are possible. No further information is expected.
Wound at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INJURY (Wound at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE INJURY (Wound at injection site). At the time of the report, INJECTION SITE INJURY (Wound at injection site) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Immediately following vaccine, client reported visual disturbance, couldn't see, pale, clammy, dilated pupils. Resolved after one minute.
BLOODY NOSE; BODY ACHE; HEADACHE; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (BLOODY NOSE), PAIN (BODY ACHE) and HEADACHE (HEADACHE) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN (BODY ACHE) and HEADACHE (HEADACHE). On 05-Mar-2021, the patient experienced EPISTAXIS (BLOODY NOSE). At the time of the report, EPISTAXIS (BLOODY NOSE), PAIN (BODY ACHE) and HEADACHE (HEADACHE) outcome was unknown.            Reporter did not allow further contact
Pericarditis; had a multi-inflammatory thing going; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERICARDITIS (medically significant) with onset 2021, outcome "not recovered"; INFLAMMATION (medically significant) with onset 2021, outcome "not recovered", described as "had a multi-inflammatory thing going". The events "pericarditis" and "had a multi-inflammatory thing going" required physician office visit. The patient underwent the following laboratory tests and procedures: Electrocardiogram: Unknown Results. Clinical course: The patient stated he filed an adverse event report in Feb2021 or Mar2021 and was wondering why there was no follow-up from Pfizer about this. He had spoken with the drug safety department and they referred him to medical information. The patient explained that he experienced Pericarditis after receiving the Pfizer Covid vaccine. He received the vaccine and had a multi-inflammatory thing going and felt he still had effects. He stated he went into his cardiologist to get an EKGs because he had symptoms and was unsure if they were related to the vaccine. He had Pericarditis inflammatory issues after he received the vaccine in 2021. He went to the hospital (further not clarified). He had Pericarditis inflammation of the heart.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT STARTED 8 DAYS AFTER THE VACCINE DEVELOPING "WHEELS" ON THE UNDER SIDE OF LEFT ARM, CHEST, RIGHT ARM AND UPPER THIGHS.  SOME SPOTS STARTED AS BRUISING THAT WAS TENDER TO THE TOUCH, THEN TURNED RED
bruising; injection site became swollen; injection site became hot; injection site became red; malaise; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd April 2022, the patient received the 1st dose of Shingrix. On 22nd April 2022, less than a day after receiving Shingrix, the patient experienced injection site swelling, injection site warmth, injection site erythema and malaise. On 27th April 2022, the patient experienced contusion. On an unknown date, the outcome of the injection site swelling, injection site warmth and injection site erythema were unknown and the outcome of the malaise was recovered/resolved and the outcome of the contusion was not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling, injection site warmth, injection site erythema, malaise and contusion to be related to Shingrix.   Additional Information: GSK Receipt Date: 27-APR-2022 Reporter's Comment: The case was reported by the patient. The patient stated that, she experienced malaise for three day.  The patient stated that, the injection site became swollen, hot, and red and five days after her arm was showing bruising. The reporter was given medical disclaimer and referred to healthcare professional. Spoke per package insert and content. Provided medical information phone number for health care professional reference. The reporter consented to follow up. Additional Supportive Information: The case had been linked to US2022070818, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022070818:Same reporter
Developed an abscess at site of injection.  Received antibiotics and warm compresses to site which helped relieve abscess.
Chills, muscle aches, head ache, flu like systems, soreness at injection site
This spontaneous report as received from a other refers to a 65 year old male patient. On 14-AUG-2017 the patient was vaccinated with ZOSTAVAX for prophylaxis. Other suspect therapies included sterile diluent (STERILE DILUENT). On 15-AUG-2017, 2 days after onset of therapy the patient experienced tinnitus. The outcome of tinnitus was reported as not recovered/not resolved. Additional information has been requested.
I found a lump (about the size of a green grape) in my right breast.  This was new from all previous exams.  I had a diagnostic mammogram and ultrasound.  It was then recommended I proceed with a biopsy.  The type of tissue was not able to be accurately identified between a fibroadenoma or another fibroid benign tumor and I have been sent for a surgical consult for removal.  That consultation is scheduled for a later date.
FULL DOSE WAS NOT ADMINISTERED AS SOME LEAKED OUT ON PATIENT'S ARM AND IMMUNIZER'S GLOVE.
Chronic fatigue since taking the vaccine, almost narcoleptic including taking unplanned naps.  Have not needed naps prior to this, and sometimes will sleep for hours after a full night's sleep the day before.   Overall exhaustion and my underlying bloodwork is healthy.
Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Medium, Systemic: Weakness-Medium, Additional Details: Patient knelt then lay down on the floor in front of the pharmacy at the end of 15 minute waiting period and said they felt faint and nauseated. was sipping water after the shot.  Asked patient if they wished me to call for an ambulance and patient replied that she felt that it would be best to call 911 so we did. Paramedics arrived within 10 minutes of the call and assessed situation and eventually helped patient sit up. Patient stood up on their own and was wheeled out on a chair and exited th
Patient vaccinated with Pfizer vaccine mixed with sterile water instead of 09% Normal Saline, preservative free. Consulted with agency and agency to determine next steps for patient after discovery. Re-vaccination advised and outreach team contacting impacted patient and offering to speak with a physician to discuss.
He had an incident and lost blood; He had an incident and lost blood; This spontaneous case was received on 30-Sep-2020 from a pharmacist via Med Communications (reference number: SEQW20-02629) and concerned a 73-year-old, male patient.   The patient's concurrent condition included high blood pressure. The patient's concomitant medications included unspecified high blood pressure medications.     On 21-Sep-2020, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59, dose: 0.5 ml, route of administration and anatomical location: not reported) for influenza prophylaxis. The batch number reported was 279791, expiry date: 28-May-2021.    On the same day, shortly after receiving Fluad Quadrivalent, the patient had an incident and lost blood, however it was not enough for a transfusion.   The outcome of events was not reported.   The reporter assessed events as not related to Fluad Quadrivalent. The pharmacist said that it was not related to the vaccine.  The event of 'blood loss of (NOS)' was considered to be medically significant by a Physician within Seqirus' Pharmacovigilance and Risk Management Department.  Additional information received on 06-Nov-2020 with additional information received on 12-Nov-2020 (being processed together) from pharmacist: Reference number added and reporter's email address was provided. No changes in the narrative.  Case updated on 14-Dec-2020: Correction made to information received on 30-Sep-2020: Typo in company comment amended.  Company comment: The patient experienced haemorrhage and accident (reported as 'he had an incident and lost blood') after administration of Fluad Quadrivalent. The patient's concurrent condition included high blood pressure while concomitant medications included unspecified high blood pressure medications. Causality will follow the reporter's causality assessment - not related to vaccine and more likely related to mechanical/physical accident.; Reporter's Comments: The pharmacist said that it was not related to the vaccine.; Sender's Comments: The patient experienced haemorrhage and accident (reported as 'he had an incident and lost blood') after administration of Fluad Quadrivalent. The patient's concurrent condition included high blood pressure while concomitant medications included unspecified high blood pressure medications. Causality will follow the reporter's causality assessment - not related to vaccine and more likely related to mechanical/physical accident.
pt healthy 2mo old @ time of vax;mom reports prolonged crying x 6hr (onset 1-2hr p/vax) & low grade fever (101-102) spontaneously resolved;
Approximately 5 minutes after administration of vaccine, patient felt nauseated and vomited with some relief.  Blood pressure was checked (171/94).  Approximately 50 minutes @09:20am after administration of vaccine, patient complained of mild headache.  Blood pressure was checked (148/96).  At 09:35am, patient reports no nausea.  Continues with mild headache.  Patient clinically stable.  No medications administered.  At 10:05am patient reports headache still present but is gradually subsiding.  Patient was released at 10:10am.
ITCHY; STRANGE; REDNESS ON HER FEET; WEAK; MUSCLE SORENESS; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergies, and other pre-existing medical conditions included patient takes a vitamin b for her hair. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 10:00 in left deltoid for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced itchy. On 25-MAR-2021, the subject experienced strange. On 25-MAR-2021, the subject experienced redness on her feet. On 25-MAR-2021, the subject experienced weak. On 25-MAR-2021, the subject experienced muscle soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from redness on her feet, and the outcome of muscle soreness, itchy, weak and strange was not reported. This report was non-serious.
Reported that she felt tingling down her arm after vaccine administered and a few hours later her arm feels numb.
15 minutes post inj pt reports her heart pounding and a tightening around her throat. Vitals taken at this time and all WNL. Benadryl administered PO. Crackers and juice provided. 25 minutes post inj pt reports tingling in her fingers but pounding heart and tightening has resolved. Pt monitored for a total of 45 minutes post symptoms, all symptoms completely resolved by discharge.
Pt recvd vax & 5 days p/dose had rash over entire body; pt was seen by MD; event resolved p/7 days;